Timothy Boire

Timothy Boire serves as President and CEO at VenoStent, Inc.. VenoStent, Inc. operates in the medical devices sector with approximately 35.0 employees. The company is headquartered in Nashville, Tennessee. VenoStent, Inc. generates annual revenue of 9800000.0. To date, VenoStent, Inc. has raised 26627824.0 in total funding, with the most recent round being Series A.

Industry & Role Insights

• • MessageCEO tracks 1,888 executives in the medical devices sector.
• • 1,282 executive contacts are available in Tennessee.
• • Our database includes 201,469 c suite-level executives.

Gmail Google Apps Mobile Friendly Typekit Node.js Android Circle SharePoint Remote Razorpay

bioengineered vascular support dialysis access vascular surgery outcomes perivascular wrap bioabsorbable materials arteriovenous access hemodialysis chronic kidney disease clinical trial nephrology selfwrap medical device 3d printing tissue engineering surgical innovation preventing access site failure patient outcomes biomimetic support vein graft patency treatment for kidney disease fda approval biomedical engineering patient quality of life research & development breakthrough device randomized controlled trial investigational device proven efficacy vascular access surgery novel technology device design designation multi-center trial vascular intervention alleviating complications external mechanical support patient-centered care clinical research stakeholder collaboration patency improvement surgical device development kidney dialysis solutions safety & effectiveness medical research funding healthcare innovation arterial health medical technology advanced materials surgical procedure efficiency hospital & health care material science

YM

Yahia Megahed CEO at 360Imaging

HA

Hugo Azevedo Chief Technology Officer at 3B Scientific

MP

Marie-Laure Pochon CEO & President at 3DISC

KD

Khanh Duy Co-CEO at 3D-Side

K

Khanh Co-CEO at 3D-Side

Outreach Guidance — medical devices Sector

Executives like Timothy Boire in the medical devices sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at VenoStent, Inc..

Timothy Boire's Position in the MessageCEO Database

• •1,787 verified executive contacts in medical devices are in the MessageCEO database.
• •1,180 verified executive contacts in Tennessee are in the database.
• •22 verified contacts work at medical devices companies in the 35.0 employee range (same size as VenoStent, Inc.).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Timothy Boire directly?

Timothy Boire's verified email address is available to MessageCEO Pro subscribers. They currently serve as President and CEO at VenoStent, Inc.. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Timothy Boire work for?

Timothy Boire is President and CEO at VenoStent, Inc., a company in the medical devices sector with 35.0 employees. The company is based in Nashville, Tennessee.

Can I pitch or sell to Timothy Boire?

As President and CEO at VenoStent, Inc., Timothy Boire is a key decision-maker in the medical devices sector. MessageCEO Pro gives you verified email to reach Timothy Boire directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Timothy Boire in?

Timothy Boire works in the medical devices industry as President and CEO at VenoStent, Inc.. MessageCEO provides verified contact information for executives across all major industries.

Is Timothy Boire's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Timothy Boire's profile is kept up-to-date with the latest available information.

Last updated: June 22, 2026